Pharmaceuticals
North America Neuropathic Pain Market to 2032
Revenue, 2024 ()
3,359.53
Forecast, 2032 ()
6,828.40
CAGR, 2024 - 2032
9.03%
Report Coverage
North America
North America Neuropathic Pain Market 2018-2032
North America Neuropathic Pain Market, Overview (2024-2032)
Market Growth and Projections:
- Market Size (2024): 3,359.53
- Projected Market Size (2032): 6,828.40
- CAGR (2024-2032): 9.03%
Key Findings of North America Neuropathic Pain Market
- The North America Neuropathic Pain Market is likely to grow at a CAGR of 9.03% during the forecast period of 2024 to 2032.
- North America Neuropathic Pain Marketsize was valued at 3,359.53 in 2024.
- In 2024, Prescription-Based Devices segment dominated the market with the largest market share.
- Peripheral Neuropathy in the product segment is expected to witness the fastest growth during the forecast period.
North America Neuropathic Pain Market Scope
North America Neuropathic Pain Market Segmentation & Scope
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
North America Neuropathic Pain Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 3,359.53 |
| Market Value in 2032 | 6,828.40 |
| CAGR (2024-2032) | 9.03% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Pain Type,Indication,Type,Product Type,Procedure,Technology,Modality,Mode of Purchase |
| Largest Segment | Prescription-Based Devices |
| Fastest Growing Segment | Peripheral Neuropathy |
| Major Players | Medtronic, Omron Healthcare, Inc., NEVRO CORP., Integer Holdings Corporation, Boston Scientific Corporation or its affiliates, Abbott, Others |
Market Segmentation:
-
Product Segment:
- Largest Segment (2024): Prescription-Based Devices
- Fastest Growing Segment (2024-2032): Peripheral Neuropathy
Regional Insights:
-
Leading Market (2024-2032): North America
- Key Country: U.S., leading in terms of revenue and market share by 2032.
North America Neuropathic Pain Market Company Share Analysis
| Name | Market Share | OwnnerShip | HQ | Website |
|---|---|---|---|---|
| Medtronic | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Omron Healthcare | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| NEVRO CORP. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Integer Holdings Corporation | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Boston Scientific Corporation or its affiliates | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Abbott | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Others | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
North America Neuropathic Pain Market Geographical Sales Distribution, 2018-2032
North America Neuropathic Pain Market Company Profiling
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
Frequently Asked Questions
The North America Neuropathic Pain Market is segmented based on Segmentation End User,Distribution Channel,Pain Type,Indication,Type,Product Type,Procedure,Technology,Modality,Mode of Purchase.
North America Neuropathic Pain Market was valued at USD 3,359.53(Revenue in ) in 2020.
North America Neuropathic Pain Market is projected to grow at a CAGR of 9.03% during the forecast period of 2024 to 2032.
The estimated market value of the North America Neuropathic Pain Market for final year is USD 6,828.40 ().
Related Markets
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.